alfuzosin hydrochloride
PolandDrugs containing this active substance
-
It is used to treat the symptoms of mild enlargement of the prostate gland to facilitate the flow of urine from the bladder. It may also be used in acute urinary retention to help restore urine flow.
Form: tablets, prolonged release
Active substance Dosage alfuzosin hydrochloride 10 mg ATC: G04CA01
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used to treat moderate to severe symptoms of benign prostatic hyperplasia. It helps to relax the muscles of this gland, which facilitates urination.
Form: tablets, prolonged release
Active substance Dosage alfuzosin hydrochloride 10 mg ATC: G04CA01
Manufacturer: Orion Corporation
-
The medicine is used to treat moderate to severe symptoms associated with an enlarged prostate (benign prostatic hyperplasia). It helps to relax the muscles of the prostate and the bladder neck, which facilitates urination.
Form: tablets, prolonged release
Active substance Dosage alfuzosin hydrochloride 10 mg ATC: G04CA01
Manufacturer: STADA Arzneimittel AG
-
It is used in the treatment of functional disorders caused by mild enlargement of the prostate gland when surgical treatment has been postponed. It helps to reduce the sensation of bladder fullness and difficulty in urination.
Form: tablets, film-coated, prolonged release
Active substance Dosage alfuzosin hydrochloride 5 mg ATC: G04CA01
Manufacturer: Sanofi Winthrop Industry
-
It is used in the treatment of functional disorders caused by mild prostatic enlargement (it reduces the sensation of bladder fullness and facilitates urination) and as adjuvant therapy in patients with an indwelling catheter due to acute urinary retention.
Form: tablets, prolonged release
Active substance Dosage alfuzosin hydrochloride 10 mg ATC: G04CA01
Manufacturer: Sanofi Winthrop Industry